设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
GSW全文库(2)
CNKI会议论文(3)
CNKI期刊论文0611(8)
Springer电子图书(2)
CNKI学位论文(13145)
知网期刊论文(12649)
在“
Elsevier电子期刊
”中,
命中:
5,337
条,耗时:0.1449283 秒
在所有数据库中总计命中:
25,809
条
1.
Phase
II
Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO
Trial
作者:
Monica Cabrero
1
;
Alejandro Martin
1
;
amartingar@usal.es
;
Javier Briones
2
;
Jorge Gayoso
3
;
Isidro Jarque
4
;
Javier Ló
;
pez
5
;
Carlos Grande
6
;
Inmaculada Heras
7
;
Reyes Arranz
8
;
Teresa Bernal
9
;
Estefania Perez-Lopez
1
;
Oriana Ló
;
pez-Godino
7
;
Eulogio Conde
10
;
Dolores Caballero
1
关键词:
Allogeneic transplantation
;
Reduced-intensity conditioning
;
Radioimmunotherapy
;
B cell lymphoma
;
Clinical
trial
刊名:Biology of Blood and Marrow Transplantation
出版年:2017
2.
Phase
II
study of irinotecan in combination with bevacizumab in recurrent ovarian cancer
作者:
Fernanda Musa
a
;
1
;
Bhavana Pothuri
a
;
Stephanie V. Blank
a
;
Huichung T. Ling
b
;
2
;
James L. Speyer
b
;
John Curtin
a
;
Leslie Boyd
a
;
Xiaochun Li
c
;
Judith D. Goldberg
c
;
Franco Muggia
b
;
Amy Tiersten
b
;
3
;
tiersten@mssn.edu
关键词:
Clinical
trial
;
Phase
II
;
Ovarian cancer
;
Bevacizumab
;
Irinotecan
刊名:Gynecologic Oncology
出版年:2017
3.
Pharmacokinetics of tiotropium administered by Respimat
®
in asthma patients: Analysis of pooled data from
Phase
II
and III clinical
trial
s
作者:
Ashish Sharma
a
;
Ashish.Sharma@boehringer-ingelheim.com
;
Huib A.M. Kerstjens
b
;
René
;
Aalbers
c
;
Petra Moroni-Zentgraf
d
;
Benjamin Weber
a
;
Ronald Dahl
e
关键词:
Tiotropium
;
Pharmacokinetics
;
Asthma
;
Respimat®
;
inhaler
刊名:Pulmonary Pharmacology & Therapeutics
出版年:2017
4.
Long-term outcomes of a
phase
II
trial
of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer
作者:
Hester Lieng
a
;
b
;
Melania Pintilie
c
;
Andrew Bayley
a
;
b
;
Alejandro Berlin
a
;
b
;
Robert Bristow
a
;
b
;
Peter Chung
a
;
b
;
Mary Gospodarowicz
a
;
b
;
Roger Huang
a
;
b
;
d
;
Cynthia Mé
;
nard
a
;
b
;
e
;
Padraig Warde
a
;
b
;
Charles Catton
a
;
b
;
charles.catton@rmp.uhn.ca
关键词:
Prostate cancer
;
Hypofractionation
;
Radiotherapy
;
Outcomes
;
Late toxicity
刊名:Radiotherapy and Oncology
出版年:2017
5.
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized
phase
II
clinical
trial
of one fraction of 19 Gy or two fractions of 13.5 Gy
作者:
Gerard Morton
;
gerard.morton@sunnybrook.ca
;
Hans T. Chung
;
Merrylee McGuffin
;
Joelle Helou
;
Laura D&rsquo
;
Alimonte
;
Ananth Ravi
;
Patrick Cheung
;
Ewa Szumacher
;
Stanley Liu
;
Motasem Al-Hanaqta
;
Liying Zhang
;
Alexandre Mamedov
;
Andrew Loblaw
关键词:
HDR
;
Monotherapy
;
Randomized
Trial
;
EPIC
;
Toxicity
刊名:Radiotherapy and Oncology
出版年:2017
6.
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter
Phase
II
Clinical
Trial
(INTERTECC-2)
作者:
Loren K. Mell
;
MD
&lowast
;
;
lmell@ucsd.edu
;
Igor Sirá
k ;
MD
;
PhD
&dagger
;
;
Lichun Wei
;
MD
&Dagger
;
;
Rafal Tarnawski
;
MD
;
PhD
§
;
;
Umesh Mahantshetty
;
MD
‖
;
Catheryn M. Yashar
;
MD
&lowast
;
;
Michael T. McHale
;
MD
¶
;
;
Ronghui Xu
;
PhD
¶
;
;
Gordon Honerkamp-Smith
;
PhD
¶
;
;
Ruben Carmona
;
MD
¶
;
;
Mary Wright
;
BS
¶
;
;
Casey W. Williamson
;
MD
&lowast
;
;
Linda Kasaová
;
PhD
&dagger
;
;
Nan Li
;
PhD
&lowast
;
;
Stephen Kry
;
PhD
#
;
Jeff Michalski
;
MD
&lowast
;
&lowast
;
;
Walter Bosch
;
PhD
&lowast
;
&lowast
;
;
William Straube
;
MS
&lowast
;
&lowast
;
;
Julie Schwarz
;
MD
;
PhD
&dagger
;
&dagger
;
;
Jessica Lowenstein
;
PhD
¶
;
;
Steve B. Jiang
;
PhD
¶
;
;
Cheryl C. Saenz
;
MD
¶
;
;
Steve Plaxe
;
MD
¶
;
;
John Einck
;
MD
&lowast
;
;
Chonlakiet Khorprasert
;
MD
&Dagger
;
&Dagger
;
;
Paul Koonings
;
MD
§
;
§
;
;
Terry Harrison
;
MD
§
;
§
;
;
Mei Shi
;
MD
&Dagger
;
;
A.J. Mundt
;
MD
&lowast
;
;
for the INTERTECC Study Group
刊名:International Journal of Radiation Oncology*Biology*Physics
出版年:2017
7.
HALT-D: A
Phase
II
Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens
作者:
Jennifer J. Gao
1
;
Ming Tan
2
;
Paula R. Pohlmann
3
;
Sandra M. Swain
3
;
Sandra.Swain@georgetown.edu
关键词:
Breast cancer
;
Chemotherapy induced diarrhea
;
Crofelemer
;
HER2
;
Pertuzumab
刊名:Clinical Breast Cancer
出版年:2017
8.
A
phase
II
evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study
作者:
Carolyn K. McCourt
;
MD
a
;
mccourtc@wudosis.wustl.edu
;
Wei Deng
;
PhD
b
;
wdeng@gogstats.org
;
Don S. Dizon
;
MD
c
;
ddizon@mgh.harvard.edu
;
Heather A. Lankes
;
PhD MPH
b
;
hlankes@gogstats.org
;
Michael J. Birrer
;
MD PhD
c
;
mbirrer@partners.org
;
Michele M. Lomme
;
MD
d
;
mlomme@wihri.org
;
Matthew A. Powell
;
MD
e
;
mpowell@wustl.edu
;
James E. Kendrick
;
MD
f
;
tkendrick2@gmail.com
;
Joel N. Saltzman
;
MD
g
;
Joel.Saltzman@uhhospitals.org
;
David Warshal
;
MD
h
;
warshal-david@cooperhealth.edu
;
Meaghan E. Tenney
;
MD
i
;
meaghan.tenney@northside.com
;
David M. Kushner
;
MD
j
;
dmkushner@wisc.edu
;
Carol Aghajanian
;
MD
k
;
aghajanc@mskcc.org
关键词:
Ixabepilone
;
Carcinosarcoma
刊名:Gynecologic Oncology
出版年:2017
9.
Factors associated with failure of oncology drugs in late-stage clinical development: A systematic review
作者:
Denis L. Jardim
a
;
jardimde@gmail.com
;
Eric S. Groves
b
;
Philip P. Breitfeld
c
;
Razelle Kurzrock
d
关键词:
Drug development
;
Precision medicine
;
Phase
II
I
trial
s
;
Biomarker
;
FDA
刊名:Cancer Treatment Reviews
出版年:2017
10.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage
II
I Breast Cancer: A
Phase
II
Trial
of the NSABP Foundation Research Group, FB-5
作者:
John W. Smith
II
1
;
2
;
Marc E. Buyse
3
;
Priya Rastogi
1
;
4
;
rastogip@upmc.edu
;
Charles E. Geyer Jr.
1
;
5
;
Samuel A. Jacobs
1
;
4
;
Erica J. Patocskai
1
;
6
;
André
;
Robidoux
1
;
6
;
Alison K. Conlin
1
;
7
;
Bilal Ansari
1
;
8
;
George P. Keogh
1
;
9
;
Philip J. Stella
1
;
10
;
Howard M. Gross
1
;
11
;
Raymond S. Lord
1
;
12
;
Jonathan A. Polikoff
1
;
13
;
Celine Mauquoi
3
;
Eleftherios P. Mamounas
1
;
14
;
Sandra M. Swain
1
;
15
;
16
;
Norman Wolmark
1
;
17
关键词:
Neoadjuvant chemotherapy
刊名:Clinical Breast Cancer
出版年:2017
1
2
3
4
5
6
7
8
9
按检索点细分(5337)
题名(2068)
关键词(165)
文摘(3263)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.